EEF1A2 and breast cancer: Indeed, over-expression of ST6GalNAc I is able to compete with O-glycan cores biosynthesis as shown in MDA-MB-231 breast cancer cells where stable expression of ST6GalNAc I converted 22% of Core 1-based O-glycans carried by MUC1 mucin into STn [6].